Cargando…

Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study

BACKGROUND: Accurate detection of patients with minimal residual disease (MRD) after surgery for stage II colon cancer (CC) remains an urgent unmet clinical need to improve selection of patients who might benefit form adjuvant chemotherapy (ACT). Presence of circulating tumor DNA (ctDNA) is indicati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schraa, S. J., van Rooijen, K. L., van der Kruijssen, D. E. W., Rubio Alarcón, C., Phallen, J., Sausen, M., Simmons, J., Coupé, V. M. H., van Grevenstein, W. M. U., Elias, S., Verkooijen, H. M., Laclé, M. M., Bosch, L. J. W., van den Broek, D., Meijer, G. A., Velculescu, V. E., Fijneman, R. J. A., Vink, G. R., Koopman, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441668/ https://www.ncbi.nlm.nih.gov/pubmed/32819390 http://dx.doi.org/10.1186/s12885-020-07252-y

Ejemplares similares

Cell-Free Circulating (Tumor) DNA before Surgery as a Prognostic Factor in Non-Metastatic Colorectal Cancer: A Systematic Review
por: Schraa, Suzanna J., et al.
Publicado: (2022)

Pathological Complete Response Following Different Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis
por: Hoendervangers, S., et al.
Publicado: (2020)

Performance of four platforms for KRAS mutation detection in plasma cell-free DNA: ddPCR, Idylla, COBAS z480 and BEAMing
por: Vessies, D. C. L., et al.
Publicado: (2020)

Comparison of NTRK fusion detection methods in microsatellite-instability-high metastatic colorectal cancer
por: Schraa, Suzanna J., et al.
Publicado: (2023)

Translation of IDEA trial results into clinical practice: Analysis of the implementation of a new guideline for colon cancer
por: van Rooijen, Karlijn L., et al.
Publicado: (2022)

The Prospective Dutch Colorectal Cancer (PLCRC) cohort: real-world data facilitating research and clinical care
por: Derksen, Jeroen W. G., et al.
Publicado: (2021)

Survival of Patients with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer Receiving Curative-Intent Local Treatment of Metastases in a Nationwide Cohort
por: Zwart, Koen, et al.
Publicado: (2023)

Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells
por: van 't Erve, Iris, et al.
Publicado: (2023)

The Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care
por: van der Meijde, Elisabeth, et al.
Publicado: (2016)

Timing of rectal cancer surgery after short-course radiotherapy: national database study
por: Verweij, Maaike E, et al.
Publicado: (2023)

Time‐varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population‐based study and meta‐analysis
por: van der Kruijssen, Dave E. W., et al.
Publicado: (2022)

MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer
por: van den Broek, Evert, et al.
Publicado: (2018)

Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN)
por: Jongeneel, Gabrielle, et al.
Publicado: (2020)

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases
por: Goos, J A C M, et al.
Publicado: (2014)

Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis
por: Goos, J A C M, et al.
Publicado: (2013)

KRAS A146 Mutations Are Associated With Distinct Clinical Behavior in Patients With Colorectal Liver Metastases
por: van 't Erve, Iris, et al.
Publicado: (2021)

Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study
por: den Uil, Sjoerd H., et al.
Publicado: (2019)

The impact of retractor SPONGE-assisted laparoscopic surgery on duration of hospital stay and postoperative complications in patients with colorectal cancer (SPONGE trial): study protocol for a randomized controlled trial
por: Couwenberg, Alice M., et al.
Publicado: (2016)

RandomizEd controlled trial for pre-operAtive dose-escaLation BOOST in locally advanced rectal cancer (RECTAL BOOST study): study protocol for a randomized controlled trial
por: Burbach, JP Maarten, et al.
Publicado: (2015)

Longitudinal effects of adjuvant chemotherapy and related neuropathy on health utility in stage II and III colon cancer patients: A prospective cohort study
por: Jongeneel, Gabrielle, et al.
Publicado: (2021)

Towards Response ADAptive Radiotherapy for organ preservation for intermediate-risk rectal cancer (preRADAR): protocol of a phase I dose-escalation trial
por: Verweij, Maaike E, et al.
Publicado: (2023)

Model-based evaluation of the cost effectiveness of 3 versus 6 months’ adjuvant chemotherapy in high-risk stage II colon cancer patients
por: Jongeneel, Gabrielle, et al.
Publicado: (2020)

Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients
por: Jongeneel, Gabrielle, et al.
Publicado: (2021)

Improving clinical management of colon cancer through CONNECTION, a nation-wide colon cancer registry and stratification effort (CONNECTION II trial): rationale and protocol of a single arm intervention study
por: van den Berg, I., et al.
Publicado: (2020)

Colorectal Cancer Care and Patients’ Perceptions Before and During COVID-19: Implications for Subsequent SARS-CoV-2 Infection Waves
por: Derksen, Jeroen W G, et al.
Publicado: (2021)

Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real‐world data
por: Jongeneel, Gabrielle, et al.
Publicado: (2019)

Prognostic models in male breast cancer
por: van der Pol, Carmen C., et al.
Publicado: (2016)

Towards patient-led follow-up after curative surgical resection of stage I, II and III colorectal cancer (DISTANCE-trial): a study protocol for a stepped-wedge cluster-randomised trial
por: Swartjes, Hidde, et al.
Publicado: (2023)

Cancer detection using whole-genome sequencing of cell free DNA
por: Leary, Rebecca J., et al.
Publicado: (2013)

GeneBreak: detection of recurrent DNA copy number aberration-associated chromosomal breakpoints within genes
por: van den Broek, Evert, et al.
Publicado: (2017)

White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
por: Leal, Alessandro, et al.
Publicado: (2020)

Digital pathology in the time of corona
por: Stathonikos, Nikolas, et al.
Publicado: (2020)

Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum
por: Greijer, Astrid E., et al.
Publicado: (2008)

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence
por: den Uil, Sjoerd H, et al.
Publicado: (2016)

Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study
por: Peters, Niek A., et al.
Publicado: (2022)

KCNQ1 and lymphovascular invasion are key features in a prognostic classifier for stage II and III colon cancer
por: Uil, Sjoerd H., et al.
Publicado: (2022)

Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands
por: Kwakman, Johannes J. M., et al.
Publicado: (2017)

Genome-wide cell-free DNA fragmentation in patients with cancer
por: Cristiano, Stephen, et al.
Publicado: (2019)

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening
por: Coupé, V M H, et al.
Publicado: (2008)

Lumican and Versican Are Associated with Good Outcome in Stage II and III Colon Cancer
por: de Wit, Meike, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gu15d158q8rl895oem45qppl67